These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 370420)
1. Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostate. Schmidt JD; Scott WW; Gibbons RP; Johnson DE; Prout GR; Loening SA; Soloway MS; Chu TM; Gaeta JF; Slack NH; Saroff J; Murphy GP J Urol; 1979 Feb; 121(2):185-9. PubMed ID: 370420 [TBL] [Abstract][Full Text] [Related]
2. A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate. Loening SA; Scott WW; deKernion J; Gibbons RP; Johnson DE; Pontes JE; Prout GR; Schmidt JD; Soloway MS; Chu TM; Gaeta JF; Slack NH; Murphy GP J Urol; 1981 Jun; 125(6):812-6. PubMed ID: 7017170 [TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. Samson MK; Wasser LP; Borden EC; Wanebo HJ; Creech RH; Phillips M; Baker LH J Clin Oncol; 1987 Jan; 5(1):86-91. PubMed ID: 3543239 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized study. Scott WW; Johnson DE; Schmidt JE; Gibbons RP; Prout GR; Joiner JR; Saroff J; Murphy GP J Urol; 1975 Dec; 114(6):909-11. PubMed ID: 1104900 [TBL] [Abstract][Full Text] [Related]
5. National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report. Johnson DE; Scott WW; Gibbons RP; Prout GR; Schmidt JD; Chu TM; Gaeta J; Saroff J; Murphy GP Cancer Treat Rep; 1977; 61(2):317-23. PubMed ID: 141326 [TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer. Herr HW J Urol; 1982 Mar; 127(3):462-5. PubMed ID: 7062419 [TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of advanced prostate cancer]. Murphy GP Vopr Onkol; 1977; 23(12):26-38. PubMed ID: 146305 [No Abstract] [Full Text] [Related]
8. Chemotherapy of hormonally unresponsive prostatic carcinoma. deKernion JB; Lindner A Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a MOPP-type regimen in histiocytosis X--a Southwest Oncology Group study. Komp DM; Silva-Sosa M; Miale T; Sexauer C; Herson J Cancer Treat Rep; 1977 Aug; 61(5):855-9. PubMed ID: 329979 [TBL] [Abstract][Full Text] [Related]
10. The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate. Scott WW; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Saroff J; Murphy GP J Urol; 1976 Aug; 116(2):211-3. PubMed ID: 950706 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin. Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604 [TBL] [Abstract][Full Text] [Related]
12. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine. Alberto P; Brunner KW; Martz G; Obrecht J; Sonntag RW Cancer; 1976 Dec; 38(6):2208-16. PubMed ID: 187313 [TBL] [Abstract][Full Text] [Related]
13. The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate. Scott WW; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Saroff J; Murphy GP Trans Am Assoc Genitourin Surg; 1976; 68():24-8. PubMed ID: 1030548 [TBL] [Abstract][Full Text] [Related]
14. Comparison of adriamycin (NSC-123127) and the combination of 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in advanced prostatic cancer: a preliminary report. Eagan RT; Utz DC; Myers RP; Furlow WL Cancer Chemother Rep; 1975; 59(1):203-7. PubMed ID: 1093666 [TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide, vincristine and procarbazine in the treatment of malignant melanoma. Byrne MJ Cancer; 1976 Nov; 38(5):1922-4. PubMed ID: 791477 [TBL] [Abstract][Full Text] [Related]
16. Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II study. Izbicki RM; Amer MH; Al-Sarraf M Cancer Treat Rep; 1979 Jun; 63(6):999-1001. PubMed ID: 380805 [TBL] [Abstract][Full Text] [Related]
17. Oat cell carcinoma of the lung: combination chemotherapy with cyclophosphamide, vincristine and procarbazine. Wittes RE; Hopfan S; Wittes JT; Golbey RB; Martini N Clin Bull; 1977; 7(1):21-4. PubMed ID: 212216 [No Abstract] [Full Text] [Related]
18. Chemotherapy programs of the National Prostatic Cancer Project (NPCP). Schmidt JD; Scott WW; Gibbons R; Johnson DE; Prout GR; Loening S; Soloway M; deKernion JB; Pontes JE; Slack NH; Murphy GP Cancer; 1980 Apr; 45(7 Suppl):1937-46. PubMed ID: 6445225 [No Abstract] [Full Text] [Related]